Boundless Bio, Inc.
Pharmaceutical company · La Jolla, California, United States · Nasdaq: BOLD
Boundless Bio, Inc. is a pharmaceutical company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker BOLD. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2023.
Boundless Bio at a glance
What does Boundless Bio do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $100 million sold (2023).
Frequently asked questions about Boundless Bio
Where is Boundless Bio headquartered?
Boundless Bio, Inc. is headquartered in La Jolla, California, United States.
What does Boundless Bio do?
Boundless Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Boundless Bio a public company?
Yes. Boundless Bio, Inc. trades on Nasdaq under the ticker BOLD.
When was Boundless Bio founded?
The earliest incorporation on record for Boundless Bio, Inc. is in 2018, according to public company registers.
Similar companies
- CalciMedica, Inc.La Jolla, California, United States
- Ensysce Biosciences, Inc.La Jolla, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.